Since p53 is mutated in NB4 and HL60 cells [16, 17] and its expression did not increase in APL patient cells (Figure 2(b)), cell cycle inhibition in our tested cells might be regulated by p53-independent pathways. This evidence concerns the gene TP53 and acute promyelocytic leukemia.